Treatment is being developed by Australian biotech Ena Respiratory

First subject dosed with new drug candidate from strategic collaboration

Treatment becomes first and only biologic for HES in the US

Johnson & Johnson signs on Michigan’s Grand River to help with COVID-19 vaccine finishing work kblankenship Mon, 09/28/2020 […]

In times of Corona it is more important than ever to take care of your own heart – […]

Updated Date: Mon, 21 Sep 2020 00:00:00 EDT

Researchers reported that genetic testing is cost-effective and beneficial for newly diagnosed patients with metastatic gastrointestinal stromal tumors […]

I welcomed the news that medical school places will remain uncapped for the 2020 entry period with reticence.1 […]

GlaxoSmithKline’s Nucala targets rival AstraZeneca with FDA nod for rare white blood cell disease kblankenship Mon, 09/28/2020 – […]

FiercePharmaPolitics—Trump plans $200 cash cards for seniors, but the source of funding is unclear esagonowsky Mon, 09/28/2020 – […]